According to MarketsandMarkets™, the global Companion Animal Diagnostics Market is projected to grow from USD 3.56 billion in 2026 to USD 5.40 billion by 2031, registering a CAGR of 8.7% during the forecast period. This growth is driven by rising pet ownership, increasing veterinary healthcare expenditure, and rapid advancements in diagnostic technologies.
The growing demand for fast, accurate, and cost-effective diagnostic solutions is transforming veterinary practices and laboratories. The adoption of advanced tools such as AI-powered image analysis, automated analyzers, in-clinic molecular diagnostics, and cloud-connected platforms is enhancing clinical workflows and enabling earlier and more precise disease detection in companion animals.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173823870
Key Market Drivers
The increasing focus on preventive care, chronic disease monitoring, and personalized veterinary treatment is significantly boosting demand for advanced diagnostic solutions. Technological innovations, including liquid biopsy, improved assay chemistry, and integrated data systems, are enhancing diagnostic accuracy, traceability, and regulatory compliance. Additionally, growing collaboration among diagnostic companies, veterinary laboratories, and technology providers is fostering the development of scalable, data-driven diagnostic ecosystems.
Segment Insights
By application, the clinical pathology segment accounted for the largest market share in 2025. This segment forms the backbone of routine veterinary diagnostics, encompassing hematology, biochemistry, urinalysis, cytology, and electrolyte analysis. Its widespread adoption is driven by high testing volumes, rapid turnaround times, and its critical role in diagnosing infections, metabolic disorders, and chronic diseases in pets.
By end user, the homecare settings segment is expected to register the highest CAGR during the forecast period. The increasing adoption of at-home diagnostic solutions, coupled with rising demand for convenient and continuous pet health monitoring, is driving this segment’s growth. Advancements in digital health tools and remote diagnostics are further supporting this trend.
Regional Outlook
North America accounted for the largest share of the companion animal diagnostics market in 2025. The region’s dominance is attributed to high pet ownership rates, advanced veterinary healthcare infrastructure, and strong adoption of innovative diagnostic technologies. Additionally, increasing awareness of preventive care, availability of pet insurance, and the presence of leading market players are further supporting market growth in this region.
Speak To Analyst:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173823870
Competitive Landscape
The companion animal diagnostics market is highly competitive, with leading players focusing on innovation, partnerships, and expansion strategies. Key companies operating in this space include IDEXX Laboratories, Zoetis Services LLC, Mars, Incorporated, bioMérieux, FUJIFILM Corporation, Thermo Fisher Scientific Inc., Neogen Corporation, Virbac, INDICAL BIOSCIENCE GmbH, and Innovative Diagnostics, among others.
As veterinary healthcare continues to evolve toward precision diagnostics and digital integration, the companion animal diagnostics market is expected to witness sustained growth, driven by innovation, increasing pet care awareness, and expanding global demand.